Pulished Date August, 2019
ID: 126
Share on
Share on

Middle East & Africa In-Vitro Diagnostics Market Research Report - By Product, Technology, Application, Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis, Size, Share, Growth, Trends, Forecast | 2019 - 2024

Pulished: August, 2019
ID: 126
Pages: 145

MEA In-Vitro Diagnostics Market Size & Growth (2019 - 2024)

The size of the In-Vitro diagnostics market in the Middle East & Africa has been estimated at USD 7 billion in 2019 and is expected to reach 10.23 billion in 2024 at a Compound Annual Growth Rate (CAGR) of 6.17%.

 The rise in the number of people suffering from cancer and diabetes is straightly leveling up the demand of the market. In the Middle East and Africa, government authorities are taking initial steps to improve healthcare services with IVD products and this is enhancing the growth rate of this market. In addition, these devices are accurate and convenient to perform diagnostics tests which are propelling the demand of the in-vitro diagnostics market in the Middle East and Africa. The increasing scale of diagnostics centers and hospitals across the region is also leveling up the growth rate of the market. 

However, people in rural areas are less aware of these diagnostic procedures where it is declining the growth rate of the in-vitro diagnostics market in the Middle East and Africa. Lack of reimbursement schemes by the government in undeveloped countries is hindering the demand of the market. The major challenging factor for the market developers is strict rules and regulations by the government in approving various IVD products. Frequent changes in the economic strategies may also impact negatively the growth rate of the market in the Middle East and Africa. The dearth of skilled people in monitoring the systems effectively due to less training programs is impeding the demand of the market. 

Growing incidences of cancer, diabetes and cardiac problems among many individuals and their prevalence for effective treatment procedures is likely to bolster the demand of the market. Rising support from the public and private organizations in developing innovative products is creating growth opportunities for the market. Along with this, the prevalence of early diagnosis is straightly fuelling the growth rate of the in-vitro diagnostics market in the Middle East and Africa. Research and development institutes are focusing on launching innovative products with the latest technology in order to improve the quality of diagnostic and treatment procedures which is ascribed to boost up the demand of the market in this region. 

This research report segmented and sub-segmented into the following categories:

  • By Product: Instruments, Reagents, Kits, Software
  • By Technology: Clinical Chemistry, Hematology, Immunoassays, Coagulation and Hemostasis, Molecular Diagnostics, Microbiology and other IVD technologies
  • By Application: Diabetes, Infectious, Oncology/Cancer, Cardiology, Nephrology, Autoimmune Diseases, Drug Testing, HIV
  • By Country:  KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA

Most promising companies in the market

Companies playing a crucial role in the MEA IVD Market are Abbott Laboratories, Johnson and Johnson, Siemens Healthcare, Becton Dickinson, Roche Diagnostic, Beckman Coulter Inc., Biomérieux, Ortho Clinical Diagnostics, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Sysmex Corporation & Thermo Fisher Scientific, Inc.

  1. Introduction

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods

                1.4 General Study Assumptions

  1. Research Methodology

                2.1 Introduction                                              

                2.2 Research Phases                                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

  1. Overview

                3.1 Executive Summary                

                3.2 Key Inferences                                         

                3.3 New Developments                

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                                          

                4.2 Market Restraints                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market

  1. Market Segmentation

                5.1 By Product                                  

                                5.1.1 Instruments                           

                                5.1.2 Reagents and Kits 

                                5.1.3 Software                 

                5.2 By Technology                                          

                                5.2.1 Clinical Chemistry

                                5.2.2 Hematology                           

                                5.2.3 Immunoassays                      

                                5.2.4 Coagulation and Hemostasis

                                5.2.5 Molecular Diagnostics        

                                5.2.6 Microbiology                          

                                5.2.7 Other IVD technologies     

                5.3 By Application                                           

                                5.3.1 Diabetes                  

                                5.3.2 Infectious Diseases             

                                5.3.3 Oncology/Cancer 

                                5.3.4 Cardiology                               

                                5.3.5 Nephrology                            

                                5.3.6 Autoimmune Diseases       

                                5.3.7 Drug Testing                           

                                5.3.8 HIV                                             

  1. Geographical Analysis

                6.1 Introduction                                              

                6.2 Middle-East                                                

                6.3 Africa                                                            

  1. Strategic Analysis

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers

                                7.2.2 Bargaining Power of Consumers

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry

  1. Market Leaders' Analysis

                8.1 Abbott Laboratories               

                                8.1.1 Overview                

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues                            

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis                       

                                8.1.8 Analyst View                          

                8.2 Johnson and Johnson                             

                8.3 Siemens Healthcare                

                8.4 Becton Dickinson                     

                8.5 Roche Diagnostics                    

                8.6 Beckman Coulter Inc.                             

                8.7 Biomérieux                                

                8.8 Ortho Clinical Diagnostics, Inc.           

                8.9 Bio-Rad Laboratories, Inc.                    

                8.10 Danaher Corporation                           

                8.11 Sysmex Corporation                             

                8.12 Thermo Fisher Scientific, Inc.            

  1. Competitive Landscape

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis        

                9.3 Agreements, collaborations and Joint Ventures

                9.4 New Product Launches                          

  1. Expert Opinions

                10.1 Market Outlook                     

                10.2 Investment Opportunities 

Appendix                                                           

  1. List of Tables
  2. List of Figures

                                                                               

 

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Middle East & Africa Global In-Vitro Diagnostics Market By Region, From 2019-2024 ( USD Billion )                                                            
  2. Middle East & Africa Global In-Vitro Diagnostics Market By Type, From 2019-2024 ( USD Billion )                                                 
  3. Middle East & Africa Instruments Market By Region, From 2019-2024 ( USD Billion )                                                         
  4. Middle East & Africa Reagents and Kits Market By Region, From 2019-2024 ( USD Billion )                                                              
  5. Middle East & Africa Software Market By Region, From 2019-2024 ( USD Billion )                                               
  6. Middle East & Africa Clinical Chemistry Market By Region, From 2019-2024 ( USD Billion )                                                              
  7. Middle East & Africa Hematology Market By Region, From 2019-2024 ( USD Billion )                                                         
  8. Middle East & Africa Immunoassays Market By Region, From 2019-2024 ( USD Billion )                                                    
  9. Middle East & Africa Coagulation and Hemostasis Market By Region, From 2019-2024 ( USD Billion )                                                         
  10. Middle East & Africa Molecular Diagnostics Market By Region, From 2019-2024 ( USD Billion )                                                     
  11. Middle East & Africa Microbiology Market By Region, From 2019-2024 ( USD Billion )                                                       
  12. Middle East & Africa Other IVD technologies Market By Region, From 2019-2024 ( USD Billion )                                                   
  13. Middle East & Africa Diabetes Market By Region, From 2019-2024 ( USD Billion )                                                
  14. Middle East & Africa Infectious Diseases Market By Region, From 2019-2024 ( USD Billion )                                                           
  15. Middle East & Africa Oncology/Cancer Market By Region, From 2019-2024 ( USD Billion )                                               
  16. Middle East & Africa Cardiology Market By Region, From 2019-2024 ( USD Billion )                                                            
  17. Middle East & Africa Nephrology Market By Region, From 2019-2024 ( USD Billion )                                                          
  18. Middle East & Africa Autoimmune Diseases Market By Region, From 2019-2024 ( USD Billion )                                                     
  19. Middle East & Africa Drug Testing Market By Region, From 2019-2024 ( USD Billion )                                                        
  20. Middle East & Africa HIV Market By Region, From 2019-2024 ( USD Billion )                                                          
  21. Middle East Market By Product, From 2019-2024 ( USD Billion )                                                  
  22. Middle East Market By Technology, From 2019-2024 ( USD Billion )                                                          
  23. Middle East Market By Application, From 2019-2024 ( USD Billion )                                                           
  24. Africa Market By Product, From 2019-2024 ( USD Billion )                                                             
  25. Africa Market By Technology, From 2019-2024 ( USD Billion )                                                      
  26. Africa Market By Application, From 2019-2024 ( USD Billion )                                                      

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample